Calton & Associates’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-690	Closed	-$55K	–	317
2022 Q1	$55K	Buy	+690	New	+$55K	0.02%	345